Literature DB >> 20655402

Methodology and measurement of the effectiveness of Haemophilus influenzae type b vaccine: systematic review.

Rosalyn E O'Loughlin1, Karen Edmond, Punam Mangtani, Adam L Cohen, Sharmila Shetty, Rana Hajjeh, Kim Mulholland.   

Abstract

The use of the highly effective Haemophilus influenzae type b (Hib) conjugate vaccine has increased globally. We review the benefits and limitations of studies measuring Hib vaccine effectiveness (VE). We critically examine the case-control approach by assessing the similarities and differences in methodology and findings and discuss the need for future Hib VE studies. In the absence of good surveillance data, vaccine effectiveness studies can play an important role, particularly with the increasing use of pneumococcal vaccine that has not been well tested under field conditions in less developed countries. However, the effectiveness of Hib vaccine has been well documented so the need for future VE Hib studies is minimal. (c) 2010 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20655402     DOI: 10.1016/j.vaccine.2010.06.107

Source DB:  PubMed          Journal:  Vaccine        ISSN: 0264-410X            Impact factor:   3.641


  12 in total

1.  Cost-effectiveness of Haemophilus influenzae type b vaccine in Vietnam.

Authors:  Phuc Le; Ulla K Griffiths; Dang Duc Anh; Luisa Franzini; Wenyaw Chan; J Michael Swint
Journal:  Vaccine       Date:  2015-06-01       Impact factor: 3.641

2.  Indirect cohort analysis of 10-valent pneumococcal conjugate vaccine effectiveness against vaccine-type and vaccine-related invasive pneumococcal disease.

Authors:  Jennifer R Verani; Carla Magda A Santos Domingues; José Cassio de Moraes
Journal:  Vaccine       Date:  2015-10-24       Impact factor: 3.641

3.  The K1 capsular polysaccharide from Acinetobacter baumannii is a potential therapeutic target via passive immunization.

Authors:  Thomas A Russo; Janet M Beanan; Ruth Olson; Ulrike MacDonald; Andrew D Cox; Frank St Michael; Evgeny V Vinogradov; Brad Spellberg; Nicole R Luke-Marshall; Anthony A Campagnari
Journal:  Infect Immun       Date:  2013-01-07       Impact factor: 3.441

4.  Cost-effectiveness of the Haemophilus influenzae type b vaccine for infants in mainland China.

Authors:  Guijun Ning; Zundong Yin; Yixing Li; Huaqing Wang; Weizhong Yang
Journal:  Hum Vaccin Immunother       Date:  2017-11-27       Impact factor: 3.452

Review 5.  Two or three primary dose regime for Haemophilus influenzae type b conjugate vaccine: meta-analysis of randomized controlled trials.

Authors:  Kiran K Thumburu; Meenu Singh; Rashmi Ranjan Das; Nishant Jaiswal; Amit Agarwal; Ajay Kumar; Harpreet Kaur
Journal:  Ther Adv Vaccines       Date:  2015-03

6.  Effectiveness of Haemophilus influenzae type b conjugate vaccine on radiologically-confirmed pneumonia in young children in Pakistan.

Authors:  Asif Raza Khowaja; Syed Mohiuddin; Adam L Cohen; Waseem Mirza; Naila Nadeem; Talha Zuberi; Basit Salam; Fatima Mubarak; Bano Rizvi; Yousuf Husen; Khatidja Pardhan; Khalid Mehmood A Khan; Syed Jamal Raza; Hassan Khalid Zuberi; Sultan Mustafa; Salma H Sheikh; Akbar Nizamani; Heermani Lohana; Kim Mulholland; Elizabeth Zell; Rana Hajjeh; Altaf Bosan; Anita K M Zaidi
Journal:  J Pediatr       Date:  2013-07       Impact factor: 4.406

7.  Progress towards demonstrating the impact of Haemophilus influenzae type b conjugate vaccines globally.

Authors:  Rana Hajjeh; Kim Mulholland; Anne Schuchat; Mathuram Santosham
Journal:  J Pediatr       Date:  2013-07       Impact factor: 4.406

8.  FOXP3+Helios+ Regulatory T Cells, Immune Activation, and Advancing Disease in HIV-Infected Children.

Authors:  Alka Khaitan; Adam Kravietz; Mussa Mwamzuka; Fatma Marshed; Tiina Ilmet; Swalehe Said; Aabid Ahmed; William Borkowsky; Derya Unutmaz
Journal:  J Acquir Immune Defic Syndr       Date:  2016-08-15       Impact factor: 3.731

Review 9.  Dose-specific efficacy of Haemophilus influenzae type b conjugate vaccines: a systematic review and meta-analysis of controlled clinical trials.

Authors:  U K Griffiths; A Clark; B Gessner; A Miners; C Sanderson; E R Sedyaningsih; K E Mulholland
Journal:  Epidemiol Infect       Date:  2012-05-14       Impact factor: 2.451

Review 10.  Veterinary and human vaccine evaluation methods.

Authors:  T J D Knight-Jones; K Edmond; S Gubbins; D J Paton
Journal:  Proc Biol Sci       Date:  2014-04-16       Impact factor: 5.349

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.